Pacira BioSciences, Inc.

PCRX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
144 Mar 17, 2026
144 Mar 17, 2026
SCHEDULE 13D/A Mar 12, 2026
DFAN14A Mar 12, 2026
DEFA14A Mar 11, 2026 DEFA14A
DFAN14A Mar 11, 2026
S-8 Feb 26, 2026 S-8
10-K Feb 26, 2026 10-K - PCRX - 12.31.2025
8-K Feb 26, 2026 8-K
4 Feb 13, 2026 FORM 4
4 Feb 13, 2026 FORM 4
4 Feb 13, 2026 FORM 4
4 Feb 13, 2026 FORM 4
4 Feb 13, 2026 FORM 4
4 Feb 13, 2026 FORM 4
4 Feb 3, 2026 FORM 4
4 Feb 3, 2026 FORM 4
4 Feb 3, 2026 FORM 4
4 Feb 3, 2026 FORM 4
4 Feb 3, 2026 FORM 4
144 Feb 2, 2026
144 Feb 2, 2026
4 Jan 29, 2026 FORM 4
3 Jan 29, 2026 FORM 3
8-K Jan 28, 2026 8-K
← Newer Page 4 of 53 · 1306 filings Older →